UJ scientists target cancer with ‘silver bullet’

A chance discussion over dinner has led to a revolutionary drug discovery by scientists at the University of Johannesburg. Silver thiocyanate phosphine complex, called UJ3 for short, is taking on cancer in a big way… and winning. So far, it has been successfully tested in rats and in human cancer cells in the laboratory. Human trials are still a long way away though.

Investigative TV programme Carte Blanche spoke to the researchers on this exciting project to find out exactly why experts are calling it the silver bullet.